Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study
- 9 October 2011
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 14 (3), 237-241
- https://doi.org/10.1111/j.1399-3062.2011.00686.x
Abstract
Background Yellow fever (YF) may be very serious, with mortality reaching 50%. Live attenuated virus YF vaccine (YFV) is effective, but may present, although rare, life‐threatening side effects and is contraindicated in immunocompromised patients. However, some transplant patients may inadvertently receive the vaccine. Methods A questionnaire was sent to all associated doctors to the Brazilian Organ Transplantation Association through its website, calling for reports of organ transplanted patients who have been vaccinated against YF. Results Twelve doctors reported 19 cases. None had important side effects. Only one had slight reaction at the site of YFV injection. Eleven patients were male. Organs received were 14 kidneys, 3 hearts, and 2 livers. Twelve patients received organs from deceased donors. Mean age at YFV was 45.6 ± 13.6 years old (range 11–69); creatinine: 1.46 ± 0.62 mg/dL (range 0.8–3.4); post‐transplant time: 65 ± 83.9 months (range 3–340); and time from YFV at the time of survey: 45 ± 51 months (range 3–241). Immunosuppression varied widely with different drug combinations: azathioprine (7 patients), cyclosporine (8), deflazacort (1), mycophenolate (10), prednisone (11), sirolimus (3), and tacrolimus (4). Conclusions YFV showed no important side effects in this cohort of solid organ transplanted patients. However, owing to the small number of studied patients, it is not possible to extend these findings to the rest of the transplanted population, assuring safety. Therefore, these data are not strong enough to safely recommend YFV in organ transplanted recipients, as severe, even life‐threatening side effects may occur.Keywords
This publication has 17 references indexed in Scilit:
- Travel Medicine and the Solid Organ Transplant RecipientAmerican Journal of Transplantation, 2009
- Successful Immunization of an Allogeneic Bone Marrow Transplant Recipient with Live, Attenuated Yellow Fever VaccineJournal of Travel Medicine, 2009
- Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected PatientsClinical Infectious Diseases, 2009
- Vacinação contra febre amarela em pacientes com diagnósticos de doenças reumáticas, em uso de imunossupressoresRevista da Sociedade Brasileira de Medicina Tropical, 2009
- Adverse event reports following yellow fever vaccinationVaccine, 2008
- Vaccination in Brazilian HIV-Infected Adults: A Cross-Sectional StudyAIDS Patient Care and STDs, 2008
- Yellow Fever: Epidemiology and PreventionClinical Infectious Diseases, 2007
- Prevention of Infection in Adult Travelers After Solid Organ TransplantationAmerican Journal of Transplantation, 2005
- Yellow fever vaccine: a successful vaccination of an immunocompromised patientEuropean Journal of Haematology, 2004
- Yellow fever vaccine is safe and effective in HIV-infected patientsAIDS, 2004